| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President And CEO | President And COO
1 company
Windsor James Brian is a President And CEO at Rein Therapeutics, Inc.. Recent SEC Form 4 filings include 4 buys and 0 sells.
Estimated insider holdings value: $193 based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 5, 2024 | RNTX Rein Therapeutics, Inc. | President And CEO | Buy | 400 | $2.24 | $897.61 | New | -12.1% | -41.4% | |
| Dec 15, 2023 | RNTX Rein Therapeutics, Inc. | President And COO | Buy | 225 | $3.37 | $758.25 | New | +45.5% | -40.5% | |
| Nov 20, 2023 | RNTX Rein Therapeutics, Inc. | President And COO | Buy | 5,076 | $1.97 | $9,987.03 | +11,035% | +149.7% | +49.2% |